The first bioresorbable stent will be implanted in Tyumen Cardiology Center

Dr. Volkov will present a lecture on efficiency and safety of bioresorbable stents that are unique because manufactured from a material that may dissolve or be absorbed in the body. Then a workshop on implantation will be organized in the operating room.

Coronary artery disease (CAD) is one of the most widespread diseases in the world. It appears due to the narrowing or occlusion of arteries supplying heart with blood. The most dangerous complication of CAD is myocardial infarction; it takes the lives of thousands of people in our country annually. When prevention and drug therapy are useless and disease is in progress, physicians are applying modern treatment technologies allowing to provide care to such patients quickly and effectively.

The gold standard in the treatment of CAD is coronary stenting - technology that does not require complicated surgery. The main idea of this treatment is implantation of a tiny stent into a damaged vessel, so its blood flow is restored and the vessel is not getting narrow again. The history of this technology includes a wide variety of stents from the first metal ones till the modern, drug-eluting stents.

Bioresorbable stents are considered to be the fourth revolution in stenting. They are restoring patency after implantation and drugs elution is influencing the vessel wall within a month. In half a year astent made of polyglycolic acid is completely dissolved. Head of department of X-ray and surgical methods of diagnostics and treatment №1, Honored Doctor of the Russian Federation, Igor Zyryanov explained “Application of bioresorbable stents is one of the technologies which we call innovative; it is a progress in medicine and particularly in cardiology. We could only dream about such technology when we only started coronary interventions. Efficiency of new stents is still under study of foreign and Russian scientists, but the first results prove that it is possible to minimize risks of complications which can appear after stenting.”

At present, this technology is already being used in clinics of Moscow, Saint-Petersburg, Ekaterinburg, Orenburg, Krasnodar, Rostov-on-Don and other Russian cities.